Lefebvre PJ - Search Results

1

The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man.

Paquot N, Scheen AJ, Franchimont P, Lefebvre PJ. Paquot N, et al. Among authors: lefebvre pj. Diabete Metab. 1988 Jan-Feb;14(1):31-6. Diabete Metab. 1988. PMID: 3292305

2

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.

Scheen AJ, Gillet J, Rosenthaler J, Guiot J, Henrivaux P, Jandrain B, Lefèbvre PJ. Scheen AJ, et al. Among authors: lefebvre pj. Diabetologia. 1989 Nov;32(11):801-9. doi: 10.1007/BF00264911. Diabetologia. 1989. PMID: 2687064

3

Effects of pulsatile delivery of insulin and glucagon in humans.

Paolisso G, Scheen AJ, Albert A, Lefebvre PJ. Paolisso G, et al. Among authors: lefebvre pj. Am J Physiol. 1989 Nov;257(5 Pt 1):E686-96. doi: 10.1152/ajpendo.1989.257.5.E686. Am J Physiol. 1989. PMID: 2688437 Clinical Trial.

4

[Adaptation to sports by insulin-treated diabetics].

Jandrain B, Pirnay F, Scheen A, Lefebvre PJ. Jandrain B, et al. Among authors: lefebvre pj. Diabete Metab. 1988 Mar-Apr;14(2):127-35. Diabete Metab. 1988. PMID: 3042487 Review. French.

5

Insulin sensitivity in anorexia nervosa: a mirror image of obesity?

Scheen AJ, Castillo M, Lefèbvre PJ. Scheen AJ, et al. Among authors: lefebvre pj. Diabetes Metab Rev. 1988 Nov;4(7):681-90. doi: 10.1002/dmr.5610040705. Diabetes Metab Rev. 1988. PMID: 3069398 Review.

6

Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.

Scheen AJ, Henrivaux P, Jandrain B, Paolisso G, Lefèbvre PJ. Scheen AJ, et al. Among authors: lefebvre pj. Diabetes Care. 1987 Sep-Oct;10(5):567-72. doi: 10.2337/diacare.10.5.567. Diabetes Care. 1987. PMID: 3315513 Clinical Trial.

7

The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion.

Castillô M, Scheen AJ, Paolisso G, Lefèbvre PJ. Castillô M, et al. Among authors: lefebvre pj. Acta Endocrinol (Copenh). 1987 Nov;116(3):364-72. doi: 10.1530/acta.0.1160364. Acta Endocrinol (Copenh). 1987. PMID: 3318259 Clinical Trial.

8

U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.

Scheen AJ, Henrivaux P, Jandrain B, Lefèbvre PJ. Scheen AJ, et al. Among authors: lefebvre pj. Diabetes Care. 1987 Nov-Dec;10(6):707-11. doi: 10.2337/diacare.10.6.707. Diabetes Care. 1987. PMID: 3322727

9

[How should insulin sensitivity be evaluated in practice?].

Scheen AJ, Paquot N, Letiexhe MR, Castillo MJ, Lefebvre PJ. Scheen AJ, et al. Among authors: lefebvre pj. Diabete Metab. 1994 Nov-Dec;20(6):556-61. Diabete Metab. 1994. PMID: 7713280 Review. French. No abstract available.

10

Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology.

Castillo MJ, Scheen AJ, Lefèbvre PJ. Castillo MJ, et al. Among authors: lefebvre pj. Diabete Metab. 1995 Feb;21(1):3-25. Diabete Metab. 1995. PMID: 7781840 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters